Table 1 Clinical studies investigating the association between MVP and therapy response and survival
Author | Patients (n) | Tumour | Response | DFS | OS |
|---|---|---|---|---|---|
Izquierdo [13] | 57 | Ovarian cancer | Yes | Yes | Yes |
Schadendorf [90] | 71 | Melanoma | Yes | Â | Â |
Ramani [95] | 21 | Neuroblastoma | Â | Â | No |
Dingemans [96] | 36 | NSCLC | No | Â | No |
Linn [97] | 70 | Breast cancer | No | Â | Â |
Uozaki [98] | 60 | Osteosarcoma | Yes | Â | Yes |
Arts [81] | 115 | Ovarian cancer | No | No | No |
Pohl [99] | 99 | Breast cancer | No | No | No |
Volm [100] | 87 | NSCLC | Yes | Â | No |
Goff [101] | 29 | Ovarian cancer | No | Â | Â |
Pohl [102] | 68 | Colorrecto | No | Â | Â |
Diestra [89] | 83 | Bladder cancer | Yes | Â | Â |
Harada [103] | 57 | NSCLC | Yes | Â | Â |
Silva [93] | 78 | HNSCC | Yes | Â | Yes |